NAD+500

4.7 ★★★★★ ★★★★★ 3 Reviews | Leave a review

This essential coenzyme coordinates the redox biology and DNA repair signaling necessary for investigating metabolic resilience and cellular longevity.

$120.00

Best Sellers

Review Third-Party Certificates of Analysis:

COA

Core Analytical Specifications:

Chemical Purity Assay

Net Mass Verification

Microbial Sterility Screening

Endotoxin (LPS) Detection

Verified
Purity
Thresholds

Independent
COA
Validation

Secure
Trackable
Shipping

Synthesized, Analytically Verified, and Dispatched from United States.

Molecular Design & Functional Mechanism

NAD+ is central to energy metabolism and redox biology, and it’s commonly studied through strategies aimed at increasing NAD+ availability (often via precursors in human trials). 

What Research Shows 

  • NAD+ boosting in humans: Reviews summarize that many trials of NAD+-boosting strategies focus on whether interventions raise NAD+ metabolites and then evaluate outcomes across cardiovascular, metabolic, and muscle function domains (with variable results). 
  • Clinical pilot signals: A small open-label pilot in an older vascular-disease population evaluated effects of an NAD+-boosting approach on vascular and cognitive endpoints over a short duration. 

Why Research Teams Choose Us

  • Systems-level lever: It touches mitochondria, oxidative stress, DNA repair signaling, and metabolic resilience pathways.
  • High assay flexibility: NAD+ biology supports diverse endpoints (metabolomics, mitochondrial function, inflammation panels).
Molecular Design & Functional Mechanism

Tirzepatide is engineered to activate GIPR + GLP-1R simultaneously, enabling coordinated incretin signaling for appetite regulation, glycemic physiology, and energy-balance research. The clinical program positions it as a high-ceiling comparator for next-gen incretin work.

Tirzepatide is engineered to activate GIPR + GLP-1R simultaneously, enabling coordinated incretin signaling for appetite regulation, glycemic physiology, and energy-balance research. The clinical program positions it as a high-ceiling comparator for next-gen incretin work.

Tirzepatide is engineered to activate GIPR + GLP-1R simultaneously, enabling coordinated incretin signaling for appetite regulation, glycemic physiology, and energy-balance research. The clinical program positions it as a high-ceiling comparator for next-gen incretin work.

Disclaimer

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. Foundation Plus supplies compounds intended for laboratory research and development purposes. Products are not promoted for consumer, medical, or veterinary use. These products are not drugs, food additives, or dietary supplements and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.

Related Products

Leave a review

Compliance & Age Verification

Access to the Foundation Plus digital storefront is strictly restricted to individuals 21 years of age or older.

The compounds available on this site are intended solely for laboratory research purposes. These materials are not designed to prevent, treat, or cure any medical condition and are strictly not for human consumption. By entering this site, you verify that you meet the age requirement, acknowledge these clinical restrictions, and possess a legitimate research basis for the procurement of these products.

Please note that all compounds are provided as individual units.

I am under 21 / Exit